|This Slide: #55 of 100|
Slide #55. OPKO Health — Laboratorio Arama de Uruguay Limitada
OPKO Health (NASDAQ:OPK)
Laboratorio Arama de Uruguay Limitada
OPKO Health, Inc. (NYSE:OPK) has entered into an agreement to acquire Laboratorio Arama de Uruguay Limitada ("Arama"). Domiciled in Montevideo, Uruguay, Arama will add to our growing South American presence in the important Mercosur economic region while further complementing our business activities in Chile, Mexico and Brazil. The transaction is expected to close in January 2014.
Opko Health is a healthcare company. Co.'s reportable segments are: diagnostics, which consists of the clinical laboratory operations of its subsidiary, BioReference Laboratories, Inc. (BioReference), as well as its point-of-care operations; and pharmaceutical, which consists of the pharmaceutical operations it operates in Chile, Mexico, Ireland, Israel and Spain and its pharmaceutical research and development operations. Through BioReference, Co. provides laboratory testing services in the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health and correctional healthcare.
OPK SEC Filing Email Alerts Service
Open the OPK Page at The Online Investor »
Free OPK Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts
Strong Buy (3.50 out of 4)